| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | A G Knudson | |
| P2860 | cites work | Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis | Q22122362 |
| The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity | Q24299515 | ||
| Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 | Q24313491 | ||
| Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23) | Q72916321 | ||
| The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor | Q24316544 | ||
| The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins | Q24324729 | ||
| Mendelian inheritance of familial prostate cancer | Q24562051 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9 | Q28181962 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus | Q28242901 | ||
| Genetic mapping of a locus predisposing to human colorectal cancer | Q28268634 | ||
| Linkage of early-onset familial breast cancer to chromosome 17q21 | Q28268902 | ||
| Identification of a chromosome 18q gene that is altered in colorectal cancers | Q28274172 | ||
| APC mutations occur early during colorectal tumorigenesis | Q28274764 | ||
| A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations | Q28300121 | ||
| Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients | Q28300256 | ||
| The neurofibromatosis type 1 gene encodes a protein related to GAP | Q28301160 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system | Q28513603 | ||
| The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 | Q28609120 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene | Q29616490 | ||
| Participation of p53 protein in the cellular response to DNA damage | Q29618319 | ||
| Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms | Q29618586 | ||
| Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
| A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma | Q29618817 | ||
| Effects of an Rb mutation in the mouse | Q29619196 | ||
| Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis | Q29619200 | ||
| Identification and characterization of the familial adenomatous polyposis coli gene | Q29620382 | ||
| Microsatellite instability in cancer of the proximal colon | Q29620692 | ||
| Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines | Q30502375 | ||
| Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis | Q30531015 | ||
| Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. | Q33825340 | ||
| Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. | Q34046828 | ||
| Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients | Q34166560 | ||
| Mutation and cancer: a model for Wilms' tumor of the kidney | Q34207334 | ||
| Deletion of genes on chromosome 1 in endocrine neoplasia | Q57436791 | ||
| Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour | Q59088779 | ||
| No room at the p53 inn | Q59093958 | ||
| Proliferative patterns in colonic mucosa in familial polyposis | Q66908731 | ||
| Retinoblastoma: a prototypic hereditary neoplasm | Q67312912 | ||
| Chromosomal deletion and retinoblastoma | Q67839651 | ||
| Cytogenetic survey of 32 cancers of the prostate | Q70732843 | ||
| Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer | Q72092571 | ||
| Clonal expansion of p53 mutant cells is associated with brain tumour progression | Q34233614 | ||
| p53 functions as a cell cycle control protein in osteosarcomas | Q34254691 | ||
| Expression of recessive alleles by chromosomal mechanisms in retinoblastoma | Q34264957 | ||
| Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. | Q34334980 | ||
| A general theory of carcinogenesis | Q34744320 | ||
| Neuroblastoma consensus deletion maps to 1p36.1-2. | Q35175544 | ||
| Constitutional 1p36 deletion in a child with neuroblastoma. | Q35194318 | ||
| Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). | Q35194574 | ||
| Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. | Q35248366 | ||
| Mutation and cancer: neuroblastoma and pheochromocytoma | Q35569133 | ||
| Stem cell regulation, tissue ontogeny, and oncogenic events | Q35757499 | ||
| Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer | Q36046507 | ||
| The APC gene product in normal and tumor cells | Q36203064 | ||
| Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10 | Q36506484 | ||
| High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene | Q36760672 | ||
| Homozygous deletions within human chromosome band 9p21 in melanoma | Q37286548 | ||
| Model for the incidence of embryonal cancers: application to retinoblastoma | Q37587021 | ||
| p53 and the Li-Fraumeni syndrome | Q40910310 | ||
| Molecular characterization of the retinoblastoma susceptibility gene | Q40912798 | ||
| Chromosomal aberrations in human neuroblastomas | Q41057218 | ||
| Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis | Q41093150 | ||
| Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis | Q41163434 | ||
| Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. | Q41278990 | ||
| Structural evidence for the authenticity of the human retinoblastoma gene | Q41344591 | ||
| Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells | Q41407134 | ||
| Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome | Q41523994 | ||
| Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers | Q41553700 | ||
| Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation | Q41605307 | ||
| Guanine nucleotide biosynthesis is regulated by the cellular p53 concentration | Q41652292 | ||
| Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer | Q41686852 | ||
| Hereditary Renal-Cell Carcinoma Associated with a Chromosomal Translocation | Q41751694 | ||
| Clues to the pathogenesis of familial colorectal cancer | Q42622043 | ||
| Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome | Q44178518 | ||
| Requirement for a functional Rb-1 gene in murine development | Q44462954 | ||
| Loss of heterozygosity for 10q loci in human gliomas | Q46637661 | ||
| Familial brain tumour | Q48097571 | ||
| Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma | Q48100816 | ||
| A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor | Q48129277 | ||
| Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma | Q49170554 | ||
| Sporadic bilateral retinoblastoma and 13q- chromosomal deletion | Q52310601 | ||
| p53: a frequent target for genetic abnormalities in lung cancer. | Q52486321 | ||
| Relaxation of imprinted genes in human cancer. | Q52545355 | ||
| Association between wild type and mutant APC gene products. | Q54655882 | ||
| Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). | Q54674142 | ||
| Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. | Q55484718 | ||
| A child with 18q- syndrome and cerebellar astrocytoma. | Q55489119 | ||
| A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 | Q55670968 | ||
| Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome | Q57266956 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tumor suppressor gene | Q422445 |
| neoplasm | Q1216998 | ||
| cancer | Q12078 | ||
| P304 | page(s) | 10914-10921 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Antioncogenes and human cancer | |
| P478 | volume | 90 |
| Q42065532 | 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice |
| Q35360684 | 5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer |
| Q74127799 | A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma |
| Q81483199 | A descriptive study of second primary malignancies associated to breast cancer in a mexican Hispanic population |
| Q71244330 | A family inheriting different subtypes of acute myelogenous leukemia |
| Q72127267 | A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer |
| Q41141673 | A new cell line from human undifferentiated carcinoma of the ovary: establishment and characterization |
| Q74583090 | A novel case of infantile sacral teratoma and a constitutional t(12;15)(q13;q25) pat |
| Q55172667 | A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation. |
| Q30715214 | A p53 homologue and a novel serine proteinase inhibitor are over-expressed in lung squamous cell carcinoma |
| Q26858878 | A periodic table for cancer |
| Q41484383 | A qualitative and quantitative protein database approach identifies individual and groups of functionally related proteins that are differentially regulated in simian virus 40 (SV40) transformed human keratinocytes: an overview of the functional cha |
| Q24563121 | A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3 |
| Q34053160 | A review of the genetic and related effects of 1,3-butadiene in rodents and humans |
| Q36222472 | A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. |
| Q29977757 | APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity |
| Q24309625 | Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B |
| Q52549071 | Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. |
| Q40969242 | Alleletyping of an oligodendrocyte-type-2 astrocyte lineage derive from a human glioblastoma multiforme |
| Q73429863 | Allelic Losses from Chromosome 17 in Human Osteosarcomas |
| Q73718063 | Allelic imbalance in colorectal cancer at the CRAC1 locus in early-onset colorectal cancer |
| Q34134938 | Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers |
| Q36694764 | Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential |
| Q39836086 | Allelic loss at PTEN locus leads to progression of colorectal carcinoma among North Indian patients |
| Q84912254 | Allelic loss of 10q23.3, the PTEN gene locus in cervical carcinoma from Northern Indian population |
| Q45923538 | Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma. |
| Q43839577 | Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma |
| Q73780135 | Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct |
| Q73940404 | Allelotype analysis of intrahepatic cholangiocarcinoma |
| Q42442038 | Alteration of the PATCHED locus in superficial bladder cancer |
| Q28238279 | Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma |
| Q36438383 | Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas. |
| Q36445614 | Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression |
| Q41122958 | Alterations of the p16INK4A gene in human ovarian cancers |
| Q74360528 | Alterations of the tumour suppressor gene DCC in neuroblastoma |
| Q77668112 | Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues |
| Q28213694 | Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities |
| Q34385809 | An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation |
| Q36568051 | An immunohistochemical study of retinoblastoma gene product in normal, premalignant and malignant tissues of the uterine cervix |
| Q34306030 | An infant with Down syndrome and retinoblastoma. A possible non-fortuitous association |
| Q33853496 | Anecdotal, historical and critical commentaries on genetics. Rudolph Virchow and the genetic basis of somatic ecology |
| Q30656298 | Antisense RNA-mediated deficiency of the calpain protease, nCL-4, in NIH3T3 cells is associated with neoplastic transformation and tumorigenesis |
| Q43715475 | Assays to predict the genotoxicity of the chromosomal mutagen etoposide -- focussing on the best assay |
| Q58604423 | BRCA1/BRCA2 Mutations Shaped by Ancient Consanguinity Practice in Southern Mediterranean Populations |
| Q40848953 | Biological indices in the assessment of breast cancer |
| Q31132987 | Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis |
| Q40971362 | Both the rate and spectrum of loss of heterozygosity differ between human lymphoblastoid cells derived from various donors |
| Q42910617 | Break-induced loss of heterozygosity in fission yeast: dual roles for homologous recombination in promoting translocations and preventing de novo telomere addition |
| Q44437998 | Bromate induces loss of heterozygosity in the Thymidine kinase gene of L5178Y/Tk+/−-3.7.2C mouse lymphoma cells |
| Q73747396 | CTG triplet repeat expansion in a laryngeal carcinoma from a patient with myotonic dystrophy |
| Q36080985 | Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas |
| Q35038054 | Cancer stem cells and side population cells in breast cancer and metastasis. |
| Q36797674 | Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse |
| Q41228037 | Carcinogenesis: basic principles |
| Q93035890 | Case report: recurrent pituitary adenoma has increased load of somatic variants |
| Q46742483 | Cell biology: Developmental predisposition to cancer |
| Q46923351 | Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p. |
| Q24317659 | Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations |
| Q73738916 | Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus |
| Q42258874 | Chromosomal instability and human cancer |
| Q44470570 | Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas |
| Q35644518 | Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. |
| Q41069648 | Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro |
| Q33220432 | Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation |
| Q24291548 | Cloning and characterization of F-LANa, upregulated in human liver cancer |
| Q35903086 | Codominant interference, antieffectors, and multitarget drugs |
| Q57191694 | Colorectal cancer |
| Q33307857 | Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver |
| Q43585295 | Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats |
| Q34776622 | Comprehensive genetic analysis of cancer cells. |
| Q36309515 | Conditional deletion of menin results in antral G cell hyperplasia and hypergastrinemia |
| Q33682281 | Congenital anomalies and genetic disorders in families of children with central nervous system tumours |
| Q55388589 | Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma |
| Q40865275 | Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells |
| Q72781894 | Cooperative tumorigenic effects of germline mutations in Rb and p53 |
| Q41164531 | Curable and non-curable malignancies: lessons from paediatric cancer |
| Q35965005 | Current issues in genetic toxicology testing for microbiologists |
| Q33890654 | Cytogenetic and Molecular Evaluation in Myelodysplastic Syndrome and in Acute and Chronic Leukemia |
| Q40659528 | Cytogenetics and cytology of retinoblastomas |
| Q35033232 | Cytokine therapeutics: lessons from interferon alpha |
| Q41345492 | DCC's function takes shape in the nervous system |
| Q23910292 | DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas |
| Q34793031 | DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms |
| Q40629831 | DNA repair. DNA surveillance defect in cancer cells |
| Q36497091 | Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients |
| Q47322892 | Deletion of chromosomal region 13q14.3 in childhood acute lymphoblastic leukemia |
| Q53402021 | Determination of loss of heterozygosity in frozen and paraffin embedded tumors by denaturating high-performance liquid chromatography (DHPLC). |
| Q36865644 | Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival |
| Q34093068 | Differentiation therapy of human cancer: basic science and clinical applications |
| Q33863070 | Disabled-2 inactivation is an early step in ovarian tumorigenicity |
| Q34157665 | Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia |
| Q54166237 | Distinct genetic loci control development of benign and malignant skin tumours in mice |
| Q33818861 | Drosophila in cancer research. An expanding role. |
| Q35080493 | Efficiency of carcinogenesis with and without a mutator mutation |
| Q39996922 | Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells |
| Q74535838 | Enlarging tongue masses in neurofibromatosis type 1: MR findings of two cases |
| Q23923048 | Ethnic differences in cancer incidence: a marker for inherited susceptibility? |
| Q71167724 | Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers |
| Q42542809 | Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. |
| Q24535960 | Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice |
| Q37019357 | Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis |
| Q36986424 | Evolutionary dynamics of tumor suppressor gene inactivation. |
| Q40405380 | Expression and regulation of cyclin genes in breast cancer |
| Q54763062 | Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. |
| Q37636172 | Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences |
| Q24555213 | FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis |
| Q42268671 | Failed gene conversion leads to extensive end processing and chromosomal rearrangements in fission yeast |
| Q28284637 | Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene |
| Q48270104 | Familial gliomas. Analysis of six families with cerebral gliomas and without other inheritable syndromes |
| Q40410169 | Familial renal cell carcinoma: review of recent molecular genetics |
| Q54633363 | Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci. |
| Q41617058 | Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. |
| Q54985765 | Frequent allelic loss at 7p14-15 associated with aggressive histologic types of breast cancer. |
| Q54696633 | Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia. |
| Q71680261 | Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney |
| Q53401422 | Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. |
| Q40972502 | Genetic alterations in breast cancer. |
| Q35085395 | Genetic alterations in cancer as a result of breakage at fragile sites |
| Q40553433 | Genetic alterations in prostate adenocarcinoma. |
| Q35249770 | Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. |
| Q34167625 | Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how |
| Q30579902 | Genetic toxicology data in the evaluation of potential human environmental carcinogens |
| Q34331502 | Genetic variation in cancer predisposition: mutational decay of a robust genetic control network |
| Q34160186 | Genetically engineered rodent models of mammary gland carcinogenesis: an overview |
| Q80946836 | Genetics of colorectal cancer |
| Q55476381 | Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française. |
| Q33194830 | Haploinsufficiency of Anx7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the Anx7(+/-) mouse |
| Q38500276 | Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor |
| Q40970549 | Hereditary cancer: two hits revisited |
| Q35609575 | Hereditary kidney cancer |
| Q33738528 | High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas |
| Q24793756 | Homologous Recombination and Its Role in Carcinogenesis |
| Q34183753 | Homologous recombination as a mechanism of carcinogenesis |
| Q34169118 | Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. |
| Q60589916 | Identification of RUNX1/AML1 as a classical tumor suppressor gene |
| Q44348457 | Ikaros is a critical target during simultaneous exposure to X-rays and N-ethyl-N-nitrosourea in mouse T-cell lymphomagenesis. |
| Q46054824 | In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis |
| Q39709101 | Inbreeding abolishes the effect of parental origin of a mutant Rb-1 allele on pituitary tumorigenesis in mice |
| Q79195955 | Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma |
| Q57742300 | Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22 |
| Q40845470 | Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells |
| Q24336629 | Inhibition of Transcription Elongation by the VHL Tumor Suppressor Protein |
| Q38356866 | Insight into the functional consequences of inherited variants of the hMYH adenine glycosylase associated with colorectal cancer: complementation assays with hMYH variants and pre-steady-state kinetics of the corresponding mutated E.coli enzymes |
| Q33643327 | Insights into cancer from transgenic mouse models |
| Q53902140 | Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin. |
| Q73593460 | Intrinsic genetic instability of normal human lymphocytes and its implication for loss of heterozygosity |
| Q36798931 | Involvement of homologous recombination in carcinogenesis. |
| Q38121090 | Is PML a Tumor Suppressor? |
| Q41902429 | Is sunlight an aetiological agent in the genesis of retinoblastoma? |
| Q41121278 | Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity |
| Q73429681 | Lack of Correlation Between Survival and Allele Loss on Chromosome 7q31-32 in Primary Breast Cancer |
| Q38326205 | Leiomyoma cutis: a focused review on presentation, management, and association with malignancy |
| Q28131788 | Lessons from hereditary colorectal cancer |
| Q22252510 | Lifestyle-related factors and environmental agents causing cancer: An overview |
| Q55263081 | Localization of a target region of allelic loss to a 1-cM interval on chromosome 16p.13.13 in hepatocellular carcinoma. |
| Q74420090 | Loss of MHC class II inducibility in hyperplastic tissue in Rb-defective mice |
| Q36080488 | Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract |
| Q40571620 | Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck |
| Q57287558 | Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors |
| Q73644178 | Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer |
| Q47673425 | Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinoma |
| Q34134350 | Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation? |
| Q71113860 | Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas |
| Q41083078 | Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination |
| Q41342455 | Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1. |
| Q36645975 | Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas |
| Q35883808 | Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice. |
| Q24318831 | Mammalian homologs of seven in absentia regulate DCC via the ubiquitin-proteasome pathway |
| Q55181109 | Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. |
| Q35712405 | Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response |
| Q57275662 | Merlin: hanging tumor suppression on the Rac |
| Q37494397 | Mismatch repair genes in Lynch syndrome: a review |
| Q44631120 | Modified order of allelic replication in lymphoma patients at different disease stages |
| Q33891465 | Molecular and genetic aspects of lung cancer |
| Q40972927 | Molecular biology of leukemia for the clinician |
| Q24606677 | Molecular biology of lung cancer |
| Q76402656 | Molecular biology of prostate cancer |
| Q40922422 | Molecular biology of testicular germ cell tumors: current status |
| Q36243996 | Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. |
| Q41528285 | Molecular diagnosis of pancreas carcinoma |
| Q39670916 | Molecular diagnosis of parathyroid carcinoma: a reality in the near future |
| Q40925425 | Molecular genetics of colorectal cancer |
| Q36553814 | Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4 |
| Q34244318 | Mouse models of neurofibromatosis |
| Q28591456 | Mouse tumor model for neurofibromatosis type 1 |
| Q79172144 | Multiple endocrine neoplasia type 1 |
| Q36973287 | Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis |
| Q37630910 | Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors |
| Q40991506 | Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes |
| Q58068794 | Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer |
| Q26828446 | Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies? |
| Q74619815 | Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas |
| Q73794986 | Mutation of the RB1 gene caused unilateral retinoblastoma in early Age |
| Q37413651 | Mutator Phenotype and DNA Double-Strand Break Repair in BLM Helicase-Deficient Human Cells |
| Q41170292 | Myotonic dystrophy: will the real gene please step forward! |
| Q24684353 | Nailing down a link between tuberin and renal cysts |
| Q42834984 | Neoplastic transformation and tumorigenesis associated with sam68 protein deficiency in cultured murine fibroblasts |
| Q41176229 | Neurofibromatosis and associated tumour suppressor genes |
| Q74034483 | New target region of allelic loss in hepatocellular carcinomas within a 1-cM interval on chromosome 6q23 |
| Q40954645 | Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines |
| Q48003083 | Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas |
| Q37701211 | Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density |
| Q24803579 | On evolutionary origin of cancer |
| Q44590170 | One allele deletion of the RB1 gene in a case of refractory anemia with del(13)(q12q14): a fluorescence in situ hybridization study of the RB1 gene |
| Q35368205 | Our changing view of the genomic landscape of cancer |
| Q73429811 | P53 Overexpression as an Indicator of Overall Survival and Response to Treatment in Osteosarcomas |
| Q35092834 | PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells |
| Q48190895 | PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors |
| Q35022507 | Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 |
| Q34617395 | Patterns of Cell Division and the Risk of Cancer |
| Q41136153 | Pediatric cancer: environmental and genetic aspects |
| Q34053035 | Physical mapping of the minimal region of loss in 5q- chromosome |
| Q35895460 | Pituitary tumors in patients with MEN1 syndrome. |
| Q37285776 | Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene |
| Q24561849 | Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene |
| Q38361315 | Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones |
| Q78107676 | Prognosis for G1 cell-cycle regulators: useful for predicting course of disease and for assessment of therapy in cancer |
| Q44062726 | Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells |
| Q37229936 | Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation |
| Q35618973 | Proliferation of mutators in A cell population |
| Q49982607 | Quadruple Neoplasms following Radiation Therapy for Congenital Bilateral Retinoblastoma |
| Q73447336 | RB protein expression in human endometrial carcinomas--an immunohistochemical study |
| Q36455160 | RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice |
| Q42789357 | RET proto-oncogene mutations and rearrangements in endocrine diseases |
| Q36359897 | RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients. |
| Q40456228 | Recent advances in the molecular genetics of urogenital tumors |
| Q35047240 | Regulation of tumor suppressors by nuclear-cytoplasmic shuttling |
| Q77454454 | Replication status as a possible marker for genomic instability in cells originating from genotypes with balanced rearrangements |
| Q40171441 | Retinoblastoma and the genetic theory of cancer: an old paradigm trying to survive to the evidence |
| Q34002981 | Retinoids and ovarian cancer |
| Q33958096 | Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein |
| Q36624071 | Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters |
| Q33896232 | Risk assessment for possible carcinogens: a critical look |
| Q35929538 | Role of BRCA1 and BRCA2 mutations in pancreatic cancer |
| Q35113329 | Role of homologous recombination in carcinogenesis. |
| Q34999035 | Selection and analysis of spontaneous reciprocal mitotic cross-overs in Saccharomyces cerevisiae |
| Q59794873 | Sex Chromosome Effects on Male-Female Differences in Mammals |
| Q91592073 | Single-Gene Deletions Contributing to Loss of Heterozygosity in Saccharomyces cerevisiae: Genome-Wide Screens and Reproducibility |
| Q45863983 | Somatic mosaicism and cancer: inference based on a conditional Luria-Delbrück distribution |
| Q73035204 | Somatic mutation of the PTEN/MMAC1 gene in breast cancers with microsatellite instability |
| Q28188697 | Somatic mutation: early cancer steps depend on tissue architecture |
| Q54417578 | Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. |
| Q48379390 | Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles |
| Q34611082 | Spontaneous loss of heterozygosity in diploid Saccharomyces cerevisiae cells |
| Q40975396 | Stage-specific gene expression during hepatocarcinogenesis in the rat. |
| Q35596587 | Stem cell in gastrointestinal structure and neoplastic development |
| Q41526922 | Strategies for Approaching Retinoblastoma Tumor Suppressor Gene Therapy |
| Q35128582 | Stress alters rates and types of loss of heterozygosity in Candida albicans |
| Q42535984 | Structural analysis of aberrant chromosomes that occur spontaneously in diploid Saccharomyces cerevisiae: retrotransposon Ty1 plays a crucial role in chromosomal rearrangements |
| Q36553686 | Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene |
| Q36573886 | Subunit composition determines E2F DNA-binding site specificity |
| Q36001068 | Sunlight and skin cancer: another link revealed |
| Q24563504 | Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 |
| Q27026264 | The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations |
| Q46192247 | The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation |
| Q22009112 | The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors |
| Q33823452 | The NF1 somatic mutational landscape in sporadic human cancers |
| Q47814736 | The future: genetics advances in MEN1 therapeutic approaches and management strategies. |
| Q35660996 | The gastrointestinal stem cell |
| Q33536033 | The genetic basis of breast cancer and its clinical implications |
| Q73918278 | The influence of cytogenetic aberrations on gene replication in chronic lymphocytic leukemia patients |
| Q40041349 | The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen |
| Q34388658 | The linear process of somatic evolution. |
| Q37388054 | The melanoma differentiation associated gene mda-7 suppresses cancer cell growth |
| Q34027887 | The molecular genetics of colorectal cancer |
| Q39551053 | The non-coding oncogene: a case of missing DNA evidence? |
| Q36862486 | The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). |
| Q34235680 | The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy |
| Q34636999 | The role of individual susceptibility in cancer burden related to environmental exposure |
| Q24290817 | The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination |
| Q37272653 | The von Hippel-Lindau gene: turning discovery into therapy |
| Q35036600 | The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. |
| Q24564802 | The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins |
| Q39431542 | Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells |
| Q41687948 | Transcription factor-based drug design in anticancer drug development |
| Q24530637 | Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein |
| Q42813262 | Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells |
| Q57636194 | Tumor suppressor genes |
| Q40568235 | Tumor suppressor genes in molecular medicine |
| Q37550949 | Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias |
| Q33890086 | Tumour suppressor gene mutations in humans and mice: parallels and contrasts |
| Q33938140 | Tumour suppressor genes |
| Q74319003 | Two regions of deletion in 9p22- p24 in neuroblastoma are frequently observed in favorable tumors |
| Q41015926 | Two-dimensional DNA typing: A cost-effective way of analyzing complex mixtures of DNA fragments for sequence variations |
| Q55470193 | Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice. |
| Q24561466 | Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis |
| Q64997482 | Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins. |
| Q73812889 | [Evaluation of cancer risk through genetic analysis?] |
| Q83190779 | [Germline tp53 neomutation in a patient with Li-Fraumeni syndrome and pancreatic adenocarcinoma] |
| Q35609031 | mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine |
| Q57338202 | p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer |
Search more.